Affiliation:
1. Third Affiliated Hospital of Harbin Medical University
Abstract
Abstract
Background
Breast cancer is the most prevalent cancer worldwide, and endometrial cancer is one of the most common gynecological cancers. Observational studies have shown an association between breast and endometrial cancers, but it may be influenced by potential confounding factors. Meanwhile, Mendelian randomization (MR) studies can overcome these confounding factors to assess causality.
Methods
We obtained breast cancer data (122,977 breast cancer cases and 105,974 controls) and endometrial cancer data (12,906 endometrial cancer cases and 108,979 controls) indirectly from the Breast Cancer Association Coalition (BCAC) and the Endometrial Cancer Association Consortium (ECAC) through the IEU Open GWAS program(https://gwas.mrcieu.ac.uk/). Then, Inverse variance weighting (IVW) was used as the primary analysis method. Sensitivity analyses were performed by multiple MR methods to ensure the accuracy of the results.
Results
Based on the IVW approach, our study found that patients with endometrial cancer have an increased risk of developing breast cancer (OR:1.072; 95% CI: 1.027–1.119; p = 0.002), especially the ER + subtype of breast cancer (OR:1.072; 95% CI: 1.029–1.129; p = 0.001). Similarly, reverse MR analyses showed an increased risk of endometrial cancer in breast cancer patients (OR:1.078; 95% CI: 1.018–1.141; p = 0.009), particularly in those who were ER+ (OR:1.075; 95% CI: 1.015–1.137; p = 0.013). However, the bidirectional MR analyses did not reveal any proof of a connection between endometrial cancer and ER- breast cancer.
Conclusions
We found a bidirectional causal effect between breast and endometrial cancer, especially ER + breast cancer. Therefore, our study supports timely screening and prevention of endometrial cancer in breast cancer patients and vice versa. At the same time, we suggest further exploration of the potential pathogenic mechanisms between breast cancer and endometrial cancer.
Publisher
Research Square Platform LLC
Reference41 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA: a cancer journal for clinicians,2021
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: a cancer journal for clinicians,2018
3. Trends in breast cancer mortality by stage at diagnosis among young women in the United States;Guo F;Cancer,2018
4. Combined chemotherapy and radiation improves survival for node-positive endometrial cancer;Lee LJ;Gynecologic oncology,2012
5. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis;Liu J;Breast cancer research and treatment,2015